Natural history of choroidal neovascularization in degenerative myopia
- PMID: 6084222
- DOI: 10.1016/s0161-6420(84)34116-1
Natural history of choroidal neovascularization in degenerative myopia
Abstract
We studied 354 eyes with myopic chorioretinal degeneration by means of standard clinical evaluation and fluorescein angiography. The eyes were classified on the basis of the degree of chorioretinal degeneration found in the posterior pole. Lacquer cracks (breaks in Bruch's membrane) were noted in 82% of the 149 eyes with choroidal neovascular membranes (CNM) and in 96% of the 58 eyes with isolated subretinal hemorrhages. These hemorrhages were reabsorbed without adverse visual sequelae in 32 eyes that were followed; in 14 of these eyes that were followed closely, the average time of reabsorption was 6.4 weeks. Seventy eyes with CNM were followed for an average of 40.9 months. In 96% of these eyes the CNM remained stable or regressed, leaving an atrophic, nonexudative scar. This study indicates that CNM in degenerative myopia is usually self-limited.
Similar articles
-
[Early lesion of choroidal neovascularization. 2. Early lesion of choroidal neovascularization in pathological myopia].Nippon Ganka Gakkai Zasshi. 1993 Jan;97(1):109-16. Nippon Ganka Gakkai Zasshi. 1993. PMID: 7679542 Japanese.
-
Lacquer cracks following laser treatment of choroidal neovascularization in pathologic myopia.Retina. 1998;18(2):118-24. doi: 10.1097/00006982-199818020-00004. Retina. 1998. PMID: 9564691
-
Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization.Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234 Suppl 1:S42-50. doi: 10.1007/BF02343047. Graefes Arch Clin Exp Ophthalmol. 1996. PMID: 8871149
-
Diagnosis and laser treatment of choroidal neovascularization in age-related macular degeneration (senile macular degeneration).Yan Ke Xue Bao. 1986 Mar;2(1):58-62. Yan Ke Xue Bao. 1986. PMID: 2465919 Review. No abstract available.
-
Present indications for removal of choroidal neovascular membranes.Curr Opin Ophthalmol. 1998 Jun;9(3):23-30. doi: 10.1097/00055735-199806000-00005. Curr Opin Ophthalmol. 1998. PMID: 10182096 Review.
Cited by
-
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization.Eye (Lond). 2012 Jul;26(7):1004-11. doi: 10.1038/eye.2012.97. Epub 2012 May 18. Eye (Lond). 2012. PMID: 22595908 Free PMC article.
-
Sensitivity of fluorescein angiography alone or with SD-OCT for the diagnosis of myopic choroidal neovascularization.Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1891-900. doi: 10.1007/s00417-013-2282-y. Epub 2013 Feb 26. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23436079
-
Choroidal neovascular membrane following clear lens extraction.Clin Ophthalmol. 2007 Dec;1(4):559-61. Clin Ophthalmol. 2007. PMID: 19668537 Free PMC article.
-
Subretinal fibrosis after photodynamic therapy in subfoveal choroidal neovascularisation in highly myopic eyes.Br J Ophthalmol. 2003 Jul;87(7):856-9. doi: 10.1136/bjo.87.7.856. Br J Ophthalmol. 2003. PMID: 12812885 Free PMC article.
-
Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.Br J Ophthalmol. 2003 Feb;87(2):173-6. doi: 10.1136/bjo.87.2.173. Br J Ophthalmol. 2003. PMID: 12543746 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical